This inventor holds 3 USPTO granted patents. Top assignee: Other. Active years: 1981-1989.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Falkenberg, SE (1981)
- Lawrenceville, NJ (US) (1985 - 1989)
Company Filing History:
Years Active: 1981-1989
Title: The Innovations of Gunnar A Aberg
Introduction
Gunnar A Aberg is a notable inventor based in Lawrenceville, NJ (US). He has made significant contributions to the field of pharmaceuticals, holding a total of 3 patents. His work focuses on developing compounds that have potential therapeutic applications.
Latest Patents
Aberg's latest patents include innovative compounds aimed at stabilizing membranes and treating cardiac arrhythmias. One of his patents discloses membrane stabilizing phenoxy-piperidine compounds, which are characterized by specific chemical structures. These compounds are designed to be used in pharmaceutical preparations, offering new avenues for treatment. Another patent outlines a method and composition for treating cardiac arrhythmias, utilizing various piperidine-2-carboxylic acid derivatives as active ingredients. These advancements highlight Aberg's commitment to improving medical treatments through innovative chemistry.
Career Highlights
Throughout his career, Gunnar A Aberg has focused on the intersection of chemistry and medicine. His patents reflect a deep understanding of pharmacology and the development of effective therapeutic agents. Aberg's work has the potential to impact the treatment of various medical conditions, particularly in the realm of cardiac health.
Collaborations
Aberg has collaborated with notable colleagues, including Bo T Af Ekenstam and Peter R Maroko. These partnerships have likely contributed to the depth and breadth of his research and innovations.
Conclusion
Gunnar A Aberg's contributions to the field of pharmaceuticals through his patents demonstrate his innovative spirit and dedication to advancing medical science. His work continues to pave the way for new treatments and therapies that can benefit patients worldwide.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile